Martijn Scholte

705 total citations
15 papers, 411 citations indexed

About

Martijn Scholte is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Martijn Scholte has authored 15 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Martijn Scholte's work include Coronary Interventions and Diagnostics (14 papers), Cardiac Valve Diseases and Treatments (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Martijn Scholte is often cited by papers focused on Coronary Interventions and Diagnostics (14 papers), Cardiac Valve Diseases and Treatments (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Martijn Scholte collaborates with scholars based in Netherlands, Israel and Gabon. Martijn Scholte's co-authors include Clemens von Birgelen, Carl E. Schotborgh, Gerard C.M. Linssen, Peter W. Danse, Carine J.M. Doggen, Paolo Zocca, Marlies M. Kok, Martin G. Stoel, Marc Hartmann and Liefke C. van der Heijden and has published in prestigious journals such as The Lancet, American Heart Journal and Journal of the American Heart Association.

In The Last Decade

Martijn Scholte

15 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martijn Scholte Netherlands 10 367 299 98 56 23 15 411
Paolo Zocca Netherlands 14 584 1.6× 521 1.7× 144 1.5× 96 1.7× 32 1.4× 37 673
J. Fournadjieva United States 3 447 1.2× 391 1.3× 103 1.1× 96 1.7× 11 0.5× 5 499
Rosaly A. Buiten Netherlands 8 290 0.8× 232 0.8× 90 0.9× 52 0.9× 4 0.2× 18 314
Patrick Ohlmann United States 8 578 1.6× 463 1.5× 170 1.7× 180 3.2× 13 0.6× 13 661
Thaddeus R. Tolleson United States 8 410 1.1× 432 1.4× 128 1.3× 108 1.9× 5 0.2× 14 543
Keisuke Yasumura United States 8 223 0.6× 135 0.5× 97 1.0× 116 2.1× 8 0.3× 32 305
Igal Moarof Switzerland 9 276 0.8× 253 0.8× 93 0.9× 50 0.9× 3 0.1× 11 340
A. de Waha Germany 2 263 0.7× 228 0.8× 88 0.9× 44 0.8× 4 0.2× 2 302
J. W. Louwerenburg Netherlands 12 681 1.9× 583 1.9× 185 1.9× 211 3.8× 8 0.3× 23 762
Jung-Won Suh South Korea 5 208 0.6× 252 0.8× 64 0.7× 56 1.0× 5 0.2× 10 307

Countries citing papers authored by Martijn Scholte

Since Specialization
Citations

This map shows the geographic impact of Martijn Scholte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martijn Scholte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martijn Scholte more than expected).

Fields of papers citing papers by Martijn Scholte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martijn Scholte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martijn Scholte. The network helps show where Martijn Scholte may publish in the future.

Co-authorship network of co-authors of Martijn Scholte

This figure shows the co-authorship network connecting the top 25 collaborators of Martijn Scholte. A scholar is included among the top collaborators of Martijn Scholte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martijn Scholte. Martijn Scholte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ploumen, Eline H., Rosaly A. Buiten, Carine J.M. Doggen, et al.. (2024). Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years. PharmacoEconomics - Open. 9(1). 137–145. 1 indexed citations
2.
Ploumen, Eline H., Carine J.M. Doggen, Carl E. Schotborgh, et al.. (2024). Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials. Netherlands Heart Journal. 32(6). 254–261. 1 indexed citations
3.
Ploumen, Eline H., Rosaly A. Buiten, Paolo Zocca, et al.. (2022). Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers. Journal of the American Heart Association. 11(22). e026041–e026041. 15 indexed citations
4.
Ploumen, Eline H., Rosaly A. Buiten, Marlies M. Kok, et al.. (2020). Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials. International Journal of Cardiology. 325. 37–44. 5 indexed citations
5.
Buiten, Rosaly A., Eline H. Ploumen, Paolo Zocca, et al.. (2020). Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial. Catheterization and Cardiovascular Interventions. 96(5). E508–E515. 11 indexed citations
6.
Buiten, Rosaly A., Eline H. Ploumen, Carine J.M. Doggen, et al.. (2020). Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial. Coronary Artery Disease. 32(1). 51–57. 3 indexed citations
7.
Buiten, Rosaly A., Eline H. Ploumen, Paolo Zocca, et al.. (2019). Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents. JACC: Cardiovascular Interventions. 12(17). 1650–1660. 40 indexed citations
8.
Buiten, Rosaly A., Eline H. Ploumen, Paolo Zocca, et al.. (2019). Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels. JAMA Cardiology. 4(7). 659–659. 49 indexed citations
9.
Kok, Marlies M., Clemens von Birgelen, Naveed Sattar, et al.. (2018). Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. EuroIntervention. 14(9). e1049–e1056. 35 indexed citations
10.
Kok, Marlies M., Paolo Zocca, Rosaly A. Buiten, et al.. (2018). Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial. EuroIntervention. 14(8). 915–923. 33 indexed citations
11.
Zocca, Paolo, Marlies M. Kok, Liefke C. van der Heijden, et al.. (2018). High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial. Cardiovascular Drugs and Therapy. 32(6). 567–576. 7 indexed citations
12.
13.
Ijsselmuiden, Alexander, Maik J. Grundeken, Martijn Scholte, et al.. (2016). First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting. EuroIntervention. 11(12). 1341–1345. 9 indexed citations
14.
Lam, Ming Kai, Hanim Sen, Kenneth Tandjung, et al.. (2014). Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): Rationale and study design of the randomized TWENTE III multicenter trial. American Heart Journal. 167(4). 445–451. 21 indexed citations
15.
Scholte, Martijn, Leo Timmers, Aernout M. Beek, et al.. (2011). Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial. Trials. 12(1). 240–240. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Zocca Breakdown of academic impact, for papers by J. Fournadjieva Breakdown of academic impact, for papers by Rosaly A. Buiten Breakdown of academic impact, for papers by Patrick Ohlmann Breakdown of academic impact, for papers by Thaddeus R. Tolleson Breakdown of academic impact, for papers by Keisuke Yasumura Breakdown of academic impact, for papers by Igal Moarof Breakdown of academic impact, for papers by A. de Waha Breakdown of academic impact, for papers by J. W. Louwerenburg Breakdown of academic impact, for papers by Jung-Won Suh
Rankless by CCL
2026